Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11-valent Pneumococcal Conjugate Vaccine in Infants
NCT00169481Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2004
- Primary completion
- May 2005
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 11-valent pneumococcal conjugate vaccine in pneumococcal disease, sponsored by GSK. Started Oct 2004; status: completed.
02
Drugs
11-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT00169481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169481.